Goldman Sachs
LH icon

Goldman Sachs’s Labcorp LH Stock Holding History

Goldman Sachs’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-46,211
Closed -$6.89M – 5483
2018
Q3 		$6.89M Buy
46,211
+28,402
+159% +$4.32M ﹤0.01% 2747
2018
Q2 		$2.75M Buy
+17,809
New +$2.69M ﹤0.01% 3403
2018
Q1 		– Sell
-116
Closed -$16K – 6178
2017
Q4 		$16K Sell
116
-2,445
-95% -$323K ﹤0.01% 6145
2017
Q3 		$332K Sell
2,561
-7,915
-76% -$1.06M ﹤0.01% 5390
2017
Q2 		$1.39M Sell
10,476
-1,048
-9% -$128K ﹤0.01% 4153
2017
Q1 		$1.42M Buy
11,524
+5,122
+80% +$606K ﹤0.01% 4069
2016
Q4 		$706K Sell
6,402
-4,074
-39% -$453K ﹤0.01% 4761
2016
Q3 		$1.24M Buy
10,476
+3,259
+45% +$384K ﹤0.01% 4221
2016
Q2 		$808K Sell
7,217
-116
-2% -$12.5K ﹤0.01% 4391
2016
Q1 		$738K Buy
7,333
+1,397
+24% +$134K ﹤0.01% 4357
2015
Q4 		$631K Sell
5,936
-582
-9% -$60K ﹤0.01% 4712
2015
Q3 		$607K Buy
6,518
+232
+4% +$24K ﹤0.01% 4949
2015
Q2 		$655K Buy
6,286
+350
+6% +$36.4K ﹤0.01% 4916
2015
Q1 		$643K Sell
5,936
-7,799
-57% -$802K ﹤0.01% 4891
2014
Q4 		$1.27M Buy
13,735
+4,190
+44% +$370K ﹤0.01% 4309
2014
Q3 		$834K Sell
9,545
-1,862
-16% -$168K ﹤0.01% 4791
2014
Q2 		$1M Sell
11,407
-27,121
-70% -$2.35M ﹤0.01% 4682
2014
Q1 		$3.25M Sell
38,528
-4,307
-10% -$343K ﹤0.01% 3511
2013
Q4 		$3.36M Buy
42,835
+38,761
+951% +$3.31M ﹤0.01% 3521
2013
Q3 		$347K Sell
4,074
-10,243
-72% -$863K ﹤0.01% 5460
2013
Q2 		$1.23M Buy
+14,317
New +$1.19M ﹤0.01% 4202

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs's LH Position: Q2 2026 in Review

Goldman Sachs increased its Labcorp (LH) stake by 10% in Q2 2026, buying an estimated $10.4M and bringing the position to 435,456 shares worth $122M. The position accounts for 0.01% of the portfolio, ranked #1092.

Goldman Sachs first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $352M in Q4 2015. 1,056 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Goldman Sachs held 435,456 shares of Labcorp worth $122M as of Q2 2026.
  • Goldman Sachs bought 39,458 Labcorp shares in Q2 2026, an estimated $10.4M.
  • Labcorp made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1092 holding.
  • Goldman Sachs first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Labcorp position peaked at $352M in Q4 2015.
  • 1,056 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.